The Access to COVID-19 Tools (ACT) Accelerator

The Access to COVID-19 Tools (ACT) Accelerator

WHO/P. Phutpheng
© Credits

Since April 2020, the ACT-Accelerator partnership, launched by WHO and partners, has supported the fastest, most coordinated, and successful global effort in history to develop tools to fight a disease. With significant advances in research and development by academia, private sector and government initiatives, the ACT-Accelerator is on the cusp of securing a way to end the acute phase of the pandemic by deploying the tests, treatments and vaccines the world needs.

Consolidated Financing Framework for ACT-A Agency & In-Country Needs

Consolidated Financing Framework for ACT-A Agency & In-Country Needs

A four-page summary of the Framework can be found here

The ACT-A Facilitation Council Financial and Resource Mobilization Working Group developed this Financing Framework to clarify sources of financing that could be used to fund the budget for October 2021 to September 2022.

Specifically, this Financing Framework seeks to: 

  • Confirm the overall investment required to meet global COVID-19 tools coverage targets for vaccines, tests, treatments and PPE, and how much of that funding would need to be channelled through ACT-A agencies versus through other initiatives and domestic efforts. 
  • Identify the specific sources of financing that could be used to fund ACT-A and other complementary costs associated with the delivery of the global COVID-19 tools coverage targets, for example, donor grants, domestic resources, multilateral development bank instruments (including grants and loans) or a combination of sources. 
  • Appeal to high-income countries and major upper middle-income countries with a clear and urgent grant financing ask and expectation of fair share voluntary contributions by participants to this ‘ask’ ahead of a potential pledging event in early 2022.

Update as of 14 February 2022, some errors in some of the figures in Table 2 on page 27 were corrected.

Publication details
Number of pages: 34
Publication date: 9 February 2022
Languages: English
Publication details
Number of pages: 34
Publication date: 9 February 2022
Languages: English

Resources

All →

A four-page summary of the Framework can be found here. The ACT-A Facilitation Council Financial and Resource Mobilization Working Group developed...

The Vaccine Manufacturing Working Group (VMWG) was established by the Access to COVID-19 Tools Accelerators (ACT-Accelerator) Facilitation Council in May...

The ACT-Accelerator Commitment Tracker provides transparent reporting on funding commitments made against ACT-Accelerator Pillar budgets.Urgent action...

Note: Report updated on 15 Sept 2021 with removal of reference to the average price of antigen RDTs on page 3, removal of reference to price reductions...

This 2020-2021 Impact Report looks back at the challenges and progress of the ACT-Accelerator over the last year. It highlights the accelerated actions...

This document sets out WHO’s unique role and funding requirements to deliver on its role and work under the Access to COVID-19 Tools (ACT)-Accelerator,...

The Facilitation Council provides high-level political leadership and enabling advice on global advocacy and resource mobilization to facilitate the work of the COVID-19 Tools Accelerator (ACT-A), its global collaborative framework, and its partnerships to ensure the realization of the ACT-A vision: the rapid development, scale-up and equitable distribution of COVID-19 vaccines, therapeutics and diagnostics, underpinned by the strengthening of health systems.

Formally launched on 10 September 2020, the Council is currently co-chaired by Norway and South Africa.

Screenshot 2021-06-08 at 16.10.57